517 related articles for article (PubMed ID: 27513368)
21. Effect of Rituximab on Pulmonary Function in Bronchiolitis Obliterans Syndrome due to Graft-Versus-Host-Disease.
Brownback KR; Thomas LA; McGuirk JP; Ganguly S; Streiler C; Abhyankar S
Lung; 2017 Dec; 195(6):781-788. PubMed ID: 28894914
[TBL] [Abstract][Full Text] [Related]
22. A review of the therapeutic potential of the cysteinyl leukotriene antagonist Montelukast in the treatment of bronchiolitis obliterans syndrome following lung and hematopoietic-stem cell transplantation and its possible mechanisms.
Kordjazy N; Amini S
Ther Adv Respir Dis; 2024; 18():17534666241232284. PubMed ID: 38504551
[TBL] [Abstract][Full Text] [Related]
23. Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.
Bergeron A; Chevret S; Granata A; Chevallier P; Vincent L; Huynh A; Tabrizi R; Labussiere-Wallet H; Bernard M; Chantepie S; Bay JO; Thiebaut-Bertrand A; Thepot S; Contentin N; Fornecker LM; Maillard N; Risso K; Berceanu A; Blaise D; Peffault de La Tour R; Chien JW; Coiteux V; Socié G;
JAMA; 2017 Aug; 318(6):557-566. PubMed ID: 28787506
[TBL] [Abstract][Full Text] [Related]
24. Azithromycin for the Treatment of Obliterative Bronchiolitis after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Yadav H; Peters SG; Keogh KA; Hogan WJ; Erwin PJ; West CP; Kennedy CC
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2264-2269. PubMed ID: 27575542
[TBL] [Abstract][Full Text] [Related]
25. What are the best pulmonary function test parameters for early detection of post-lung transplant bronchiolitis obliterans syndrome in children?
Sritippayawan S; Keens TG; Horn MV; Starnes VA; Woo MS
Pediatr Transplant; 2003 Jun; 7(3):200-3. PubMed ID: 12756044
[TBL] [Abstract][Full Text] [Related]
26. Evolution of Functional Exercise Capacity in Lung Transplant Patients With and Without Bronchiolitis Obliterans Syndrome: A Longitudinal Case-Control Study.
Cebrià I Iranzo MÀ; Vos R; Verleden GM; Gosselink R; Langer D
Arch Bronconeumol (Engl Ed); 2019 May; 55(5):239-245. PubMed ID: 30595421
[TBL] [Abstract][Full Text] [Related]
27. Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical Trial of Inhaled Liposomal Cyclosporine Plus Standard-of-Care Versus Standard-of-Care Alone for Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Iacono A; Wijesinha M; Völp A; Korotun M; Terrin M
Ann Transplant; 2024 May; 29():e942823. PubMed ID: 38741362
[TBL] [Abstract][Full Text] [Related]
28. The efficacy of mesenchymal stem cells in bronchiolitis obliterans syndrome after allogeneic HSCT: A multicenter prospective cohort study.
Chen S; Zhao K; Lin R; Wang S; Fan Z; Huang F; Chen X; Nie D; Du X; Guo Z; Lin D; Xuan L; Xu N; Sun J; Peng Xiang A; Liu Q
EBioMedicine; 2019 Nov; 49():213-222. PubMed ID: 31668569
[TBL] [Abstract][Full Text] [Related]
29. Observational Study of Methotrexate in the Treatment of Bronchiolitis Obliterans Syndrome.
Sithamparanathan S; Thirugnanasothy L; Morley KE; Fisher AJ; Lordan JL; Meachery G; Parry G; Corris PA
Transplant Proc; 2016 Dec; 48(10):3387-3392. PubMed ID: 27931586
[TBL] [Abstract][Full Text] [Related]
30. Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation.
Uhlving HH; Andersen CB; Christensen IJ; Gormsen M; Pedersen KD; Buchvald F; Heilmann C; Nielsen KG; Mortensen J; Moser C; Sengeløv H; Müller KG
Biol Blood Marrow Transplant; 2015 Mar; 21(3):531-8. PubMed ID: 25498923
[TBL] [Abstract][Full Text] [Related]
31. Long-term effect of azithromycin in bronchiolitis obliterans syndrome.
Gan CT; Ward C; Meachery G; Lordan JL; Fisher AJ; Corris PA
BMJ Open Respir Res; 2019; 6(1):e000465. PubMed ID: 31673366
[TBL] [Abstract][Full Text] [Related]
32. Relationship between FEV
Kemp R; Pustulka I; Boerner G; Smela B; Hofstetter E; Sabeva Y; François C
Respir Med; 2021 Nov; 188():106608. PubMed ID: 34517199
[TBL] [Abstract][Full Text] [Related]
33. The predictive value of pulmonary function test before transplantation for chronic pulmonary graft-versus-host-disease after allogeneic hematopoietic stem cell transplantation.
Yang L; Cheng J; Li F; Qian R; Zhang X; Jin S; He X; Xu T; Hu X; Ma X; Chen J; Zhu Y; Chen F
BMC Pulm Med; 2022 Dec; 22(1):473. PubMed ID: 36510158
[TBL] [Abstract][Full Text] [Related]
34. The association of lung function changes with outcomes in children with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Jung S; Yoon HM; Yoon J; Park M; Rhee ES; Kim H; Koh KN; Lee JS; Im HJ; Yu J
Pediatr Pulmonol; 2021 Oct; 56(10):3332-3341. PubMed ID: 34357700
[TBL] [Abstract][Full Text] [Related]
35. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second.
Patterson GM; Wilson S; Whang JL; Harvey J; Agacki K; Patel H; Theodore J
J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521
[TBL] [Abstract][Full Text] [Related]
36. Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation.
Bergeron A; Chevret S; Chagnon K; Godet C; Bergot E; Peffault de Latour R; Dominique S; de Revel T; Juvin K; Maillard N; Reman O; Contentin N; Robin M; Buzyn A; Socié G; Tazi A
Am J Respir Crit Care Med; 2015 Jun; 191(11):1242-9. PubMed ID: 25835160
[TBL] [Abstract][Full Text] [Related]
37. Impact of Forced Expiratory Volume in 1 Second (FEV1) and 6-Minute Walking Distance at 3, 6, and 12 Months and Annually on Survival and Occurrence of Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation.
Fakhro M; Ingemansson R; Algotsson L; Lindstedt S
Ann Transplant; 2017 Sep; 22():532-540. PubMed ID: 28871078
[TBL] [Abstract][Full Text] [Related]
38. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.
Jain R; Hachem RR; Morrell MR; Trulock EP; Chakinala MM; Yusen RD; Huang HJ; Mohanakumar T; Patterson GA; Walter MJ
J Heart Lung Transplant; 2010 May; 29(5):531-7. PubMed ID: 20133163
[TBL] [Abstract][Full Text] [Related]
39. Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Cheng GS; Selwa KE; Hatt C; Ram S; Fortuna AB; Guerriero M; Himelhoch B; McAree D; Hoffman TC; Brisson J; Nazareno R; Bloye K; Johnson TD; Remberger M; Mattsson J; Vummidi D; Kazerooni EE; Lama VN; Galban S; Boeckh M; Yanik GA; Galban CJ
Am J Transplant; 2020 Aug; 20(8):2198-2205. PubMed ID: 32034974
[TBL] [Abstract][Full Text] [Related]
40. Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation.
Alkhunaizi M; Patel B; Bueno L; Bhan N; Ahmed T; Arain MH; Saliba R; Rondon G; Dickey BF; Bashoura L; Ost DE; Li L; Wang S; Shpall E; Champlin RE; Mehta R; Popat UR; Hosing C; Alousi AM; Sheshadri A
Transplant Cell Ther; 2023 Mar; 29(3):204.e1-204.e7. PubMed ID: 36503180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
